GSA Capital Partners’s Verona Pharma VRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-11,198
Closed -$1.2M 2123
2025
Q3
$1.2M Buy
11,198
+3,895
+53% +$407K 0.1% 294
2025
Q2
$691K Sell
7,303
-13,223
-64% -$979K 0.05% 698
2025
Q1
$1.3M Sell
20,526
-32,846
-62% -$1.96M 0.12% 227
2024
Q4
$2.48M Buy
53,372
+23,859
+81% +$896K 0.18% 49
2024
Q3
$849K Buy
+29,513
New +$726K 0.06% 578
2023
Q3
Sell
-29,432
Closed -$622K 1942
2023
Q2
$622K Buy
+29,432
New +$628K 0.06% 604
2022
Q2
Sell
-13,150
Closed -$66K 1832
2022
Q1
$66K Buy
+13,150
New +$76.5K 0.01% 1329

Other funds holding VRNA